A. Wilner

发表

Abstracts and Insights From the 2011 European Meeting in MS: Update on New Treatments, Clinical Aspects of MS, and Biomarkers CME

R. Lisak, H. Zwibel, A. Wilner, 2011 .

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Health plan paid cost of epilepsy in 2009 in the U.S.

B. Sharma, A. Wilner, A. Krueger, 2012, Epilepsy & Behavior.

Clinically Isolated Syndrome: BENEFIT of Early Treatment?

A. Wilner, 2007 .

Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency

W. Hauser, K. Meador, J. Hopp, 2009, Neurology.

Obstetrical complications and change in seizure frequency : Focus on pregnancy ( an evidence-based review ) : − − epilepsy Practice Parameter update : Management issues for women with

W. Hauser, K. Meador, J. Hopp, 2009 .

Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): I. Obstetrical complications and change in seizure frequency

K. Meador, J. Hopp, D. Thurman, 2009, Epilepsia.

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Hedonistic Homeostatic Dysregulation Syndrome: Too Much of a Good Thing?

A. Wilner, 2006 .

Efficacy and Tolerability of the New Antiepileptic Drugs , II : Treatment of Refractory Epilepsy : Report of the TTA and QSS

B. Bourgeois, W. Marks, J. Stern, 2004 .

The Falling Sickness: A History of Epilepsy From the Greeks to the Beginning of Modern Neurology

A. Wilner, 1995 .

Invited Article: Lost in a jungle of evidence: We need a compass

Faan, A. Wilner, Facp., 2018 .

Unilateral Cardioembolic Stroke in a Patient With Aortic Arch Anomaly

R. Shahripour, A. Wilner, A. Maleki, 2020, Journal of Neurology Research.

The use of levetiracetam in refractory status epilepticus

J. Szaflarski, N. Patel, A. Wilner, 2006, Seizure.

Topiramate and Metabolic Acidosis

A. Wilner, Kent Raymond, R. Pollard, 1999, Epilepsia.

Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes

W. Hauser, K. Meador, J. Hopp, 2009, Neurology.

Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): II. Teratogenesis and perinatal outcomes

W. Hauser, K. Meador, J. Hopp, 2009, Epilepsia.

Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding

W. Hauser, K. Meador, J. Hopp, 2009, Neurology.

CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): III. Vitamin K, folic acid, blood levels, and breast‐feeding

W. Hauser, K. Meador, J. Hopp, 2009, Epilepsia.

Vitamin K , folic acid , blood levels , and breastfeeding : Report of Focus on pregnancy ( an evidence-based review ) : − − epilepsy Practice Parameter update : Management issues for women with

W. Hauser, K. Meador, J. Hopp, 2009 .

Common comorbidities in women and men with epilepsy and the relationship between number of comorbidities and health plan paid costs in 2010

B. Sharma, A. Wilner, A. Krueger, 2014, Epilepsy & Behavior.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Analgesic opioid use in a health-insured epilepsy population during 2012

B. Sharma, A. Wilner, A. Krueger, 2016, Epilepsy & Behavior.

Epilepsy therapy in 2010

S. Benbadis, A. Wilner, 2010 .

Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem

A. Wilner, 2002, Epilepsy & Behavior.

Therapeutic equivalency of generic antiepileptic drugs: results of a survey

A. Wilner, 2004, Epilepsy & Behavior.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Status epilepticus and pseudostatus epilepticus

P. Bream, A. Wilner, 1993, Seizure.

Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females.

N W Wood, F Andermann, S M Sisodiya, 2001, Human molecular genetics.

Analgesic opioid use in a health-insured epilepsy population during 2012: Response to Derakhshan

B. Sharma, A. Wilner, Amy R. Thompson, 2016, Epilepsy & Behavior.

B. Bourgeois, W. Marks, J. Stern, 2004 .

Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2007 .

Neurostimulation for Epileptic Seizures: Who, When, and Where?

A. Wilner, 2014 .

Health plan paid cost of epilepsy in 2009 in the U.S.

B. Sharma, A. Wilner, Alison Soucy, 2012, Epilepsy & Behavior.

Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): II. Teratogenesis and perinatal outcomes

W. Hauser, J. Hopp, D. Thurman, 2009, Epilepsia.

Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): III. Vitamin K, folic acid, blood levels, and breast‐feeding

W. Hauser, J. Hopp, D. Thurman, 2009, Epilepsia.

Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): I. Obstetrical complications and change in seizure frequency

J. Hopp, D. Thurman, P. Pennell, 2009, Epilepsia.

Driving advice for people with epilepsy, Parkinsonʼs, and Alzheimerʼs, and their families.

A. Wilner, 2008 .

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004 .

Diagnoses, procedures, drug utilization, comorbidities, and cost of health care for people with epilepsy in 2012

B. Sharma, A. Wilner, A. N. Wilner, 2014, Epilepsy & Behavior.